Fall 2009

September 02, 2010

The President of the National Pharmaceutical Council discusses how comparative effectiveness research and value-based insurance design can reduce costs and improve healthcare quality.

September 01, 2010

This retrospective study of 558.9 million prescription claims explores how member age demographics affect prescription drug trends and provides top therapeutic classes by generation.

September 01, 2010

Focusing first on patient needs is the key to finding a meaningful and effective solution to the complex issues regarding regulation of biosimilars.

September 01, 2010

Among patients with poor statin adherence, adequate antidepressant treatment significantly improved adherence and persistence compared with inadequate or no antidepressant treatment.

September 01, 2010

Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.

September 02, 2009

The Society seeks input from both individuals and organizations as it creates a new environment of data-driven P&T best practices.

September 02, 2009

P&T committees should implement more rigorous formulary restrictions that stimulate manufacturers to meet a higher standard when bringing new therapies to market.

September 01, 2009

Differences in formulary coverage of antihypertensive medications for children between private and public insurance plans may impact physician prescribing practices and patient outcomes.

September 01, 2009

The authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.